MFDS — authorised 18 August 2023
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: likely_approved
🇰🇷 Veopoz in South Korea
MFDS authorised Veopoz on 18 August 2023
Marketing authorisation
Veopoz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Veopoz approved in South Korea?
Yes. MFDS authorised it on 18 August 2023.
Who is the marketing authorisation holder for Veopoz in South Korea?
REGENERON PHARMACEUTICALS holds the South Korean marketing authorisation.